Clinical Trial Update: Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage [Phase 1, Phase 2]

View source ↗

Summary

The clinical trial investigating intraventricular tPA after aneurysmal subarachnoid hemorrhage (Phase 1/2) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Aneurysm
• Cerebral Vasospasm
• Hydrocephalus
• Subarachnoid Hemorrhage

Drugs mentioned

• Activase (alteplase)

Snippet

Sponsor: Rush University Medical Center | Conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm | Phase 1, Phase 2 | Status: WITHDRAWN